First Tracks Biotherapeutics, Inc. · NASDAQ:TRAX
First Tracks Biotherapeutics, Inc. shareholders
As of Sep 30, 2026, 175 institutions reported holding First Tracks Biotherapeutics, Inc., 86.2% of its shares. Largest: EcoR1 Capital, LLC, TCG Crossover Management, LLC and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of First Tracks Biotherapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| EcoR1 Capital, LLC | 3.17M | 7.6% | no change | Nov 16, 2026 |
| TCG Crossover Management, LLC | 2.9M | 6.9% | no change | Nov 16, 2026 |
| BlackRock | 2.6M | 6.2% | +633K | Nov 13, 2026 |
| Affinity Asset Advisors, LLC | 2.08M | 5.0% | +47,988 | Nov 13, 2026 |
| Adage Capital Partners Gp, L.L.C. | 2.08M | 4.9% | +1.35M | Nov 16, 2026 |
| Vanguard | 2.05M | 4.9% | −179K | Nov 13, 2026 |
| Fidelity | 1.75M | 4.2% | −307K | Nov 10, 2026 |
| State Street | 1.61M | 3.8% | new | Nov 12, 2026 |
| Janus Henderson | 1.1M | 2.6% | first report | Nov 16, 2026 |
| Bank of America | 1.01M | 2.4% | +362K | Nov 16, 2026 |